TVAI on Nasdaq
Thayer Ventures Acquisition Corp II
Blank check company, listed on Nasdaq (TVAI).
Price unavailable
Last updated Oct 18, 2026.
Overview
$3.9MNet income, fiscal 20252
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Financial statements
Every line of the income statement as filed: the last 1 fiscal year, latest first.2
| Period ending | 2025-12-31 |
|---|---|
| General and administrative expenses | $1.0M |
| Loss from operations | -$1.0M |
| Share-based compensation expense | -$181.2K |
| Earnings from investments held in Trust Account | $5.1M |
| Total other income, net | $4.9M |
| Net income (loss) | $3.9M |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 4 fiscal years (annual) or 4 quarters (quarterly), latest first.2
| Period ending | 2025-12-31 | 2025-05-31 | 2024-12-31 | 2024-04-30 |
|---|---|---|---|---|
| Cash | $258.0K | $0 | ||
| Prepaid expenses | $178.9K | $0 | ||
| Total Current Assets | $436.9K | $0 | ||
| Deferred offering costs | $0 | $622.8K | ||
| Long-term prepaid insurance | $23.8K | $0 | ||
| Investments held in Trust Account | $206.4M | $0 | ||
| Total Assets | $206.8M | $622.8K | ||
| Accounts payable and accrued expenses | $26.1K | $25.9K | ||
| Accrued offering costs | $128.1K | $575.9K | ||
| Due to related party | $1.3K | $0 | ||
| Promissory note - related party | $10 | $60.4K | ||
| Total Current Liabilities | $155.5K | $662.2K | ||
| Deferred legal fees | $920.1K | $0 | ||
| Deferred underwriting fee payable | $7.6M | $0 | ||
| Total Liabilities | $8.6M | $662.2K | ||
| Class A ordinary shares subject to possible redemption, 20,125,000 and no shares at redemption value of $10.25 and $0 per share as of December 31, 2025 and 2024, respectively | $206.4M | $0 | ||
| Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding as of December 31, 2025 and 2024 | $0 | $0 | ||
| Additional paid-in capital | $0 | $24.3K | ||
| Accumulated deficit | -$8.2M | -$64.4K | ||
| Total Shareholders' Deficit | -$8.2M | -$39.4K | $0 | |
| Total Liabilities, Ordinary Shares Subject to Possible Redemption and Shareholders' Deficit | $206.8M | $622.8K | ||
| Preferred stock, par or stated value per share | $0.00 | $0.00 | ||
| Preferred stock, shares authorized | 1.0M shares | 1.0M shares | ||
| Preferred stock, shares issued | 0 shares | 0 shares | ||
| Preferred stock, shares outstanding | 0 shares | 0 shares | ||
| Temporary equity, shares issued | 20.1M shares | |||
| Stock Issued During Period, Shares, New Issues | 20.1M shares | |||
| Under writers Over Allotment Option Exercised Units | 2.6M shares |
| Period ending | 2025-12-31 | 2025-05-31 | 2024-12-31 | 2024-04-30 |
|---|---|---|---|---|
| Cash | $258.0K | $0 | ||
| Prepaid expenses | $178.9K | $0 | ||
| Total Current Assets | $436.9K | $0 | ||
| Deferred offering costs | $0 | $622.8K | ||
| Long-term prepaid insurance | $23.8K | $0 | ||
| Investments held in Trust Account | $206.4M | $0 | ||
| Total Assets | $206.8M | $622.8K | ||
| Accounts payable and accrued expenses | $26.1K | $25.9K | ||
| Accrued offering costs | $128.1K | $575.9K | ||
| Due to related party | $1.3K | $0 | ||
| Promissory note - related party | $10 | $60.4K | ||
| Total Current Liabilities | $155.5K | $662.2K | ||
| Deferred legal fees | $920.1K | $0 | ||
| Deferred underwriting fee payable | $7.6M | $0 | ||
| Total Liabilities | $8.6M | $662.2K | ||
| Class A ordinary shares subject to possible redemption, 20,125,000 and no shares at redemption value of $10.25 and $0 per share as of December 31, 2025 and 2024, respectively | $206.4M | $0 | ||
| Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding as of December 31, 2025 and 2024 | $0 | $0 | ||
| Additional paid-in capital | $0 | $24.3K | ||
| Accumulated deficit | -$8.2M | -$64.4K | ||
| Total Shareholders' Deficit | -$8.2M | -$39.4K | $0 | |
| Total Liabilities, Ordinary Shares Subject to Possible Redemption and Shareholders' Deficit | $206.8M | $622.8K | ||
| Preferred stock, par or stated value per share | $0.00 | $0.00 | ||
| Preferred stock, shares authorized | 1.0M shares | 1.0M shares | ||
| Preferred stock, shares issued | 0 shares | 0 shares | ||
| Preferred stock, shares outstanding | 0 shares | 0 shares | ||
| Temporary equity, shares issued | 20.1M shares | |||
| Stock Issued During Period, Shares, New Issues | 20.1M shares | |||
| Under writers Over Allotment Option Exercised Units | 2.6M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 1 fiscal year, latest first.2
| Period ending | 2025-12-31 |
|---|---|
| Net Income (Loss) | $3.9M |
| Formation costs paid by Sponsor in exchange for issuance of Class B ordinary shares | $0 |
| Payment of operation costs through promissory note | $10.0K |
| Earnings from investments held in Trust Account | -$5.1M |
| Deferred legal fees | $168.7K |
| Share-based compensation expense | $181.2K |
| Prepaid expenses | -$202.7K |
| Due from Sponsor | $1.7M |
| Due to related party | $1.3K |
| Accounts payable and accrued expenses | $18.2K |
| Net cash provided by operating activities | $617.1K |
| Investment of cash in Trust Account | -$201.2M |
| Net cash used in investing activities | -$201.2M |
| Proceeds from sale of Units, net of underwriting discounts paid | $197.8M |
| Proceeds from sale of Private Placement Units | $3.6M |
| Underwriters' reimbursement | $2.0M |
| Advances from Sponsor | -$1.7M |
| Proceeds from promissory note | -$158.9K |
| Payment of offering costs | -$661.7K |
| Net cash provided by financing activities | $200.9M |
| Net Change in Cash | $258.0K |
| Deferred offering costs included in accrued offering costs | $244.3K |
| Deferred offering costs paid by Sponsor in exchange for issuance of Class B ordinary shares | $0 |
| Offering costs included in deferred legal fees | $751.4K |
| Deferred offering costs paid through promissory note related party | $40.0K |
No quarter-by-quarter statement was filed.
Compare Thayer Ventures Acquisition Corp II with another company
Leadership
Who has led Thayer Ventures Acquisition Corp II, and when. Pick a name to see everywhere that person has worked.
- Chief executive officerChristopher Hemmeter May 14, 2025 to now8
- PresidentChristopher Hemmeter May 14, 2025 to now8
Board members and other officers (6)
- Board memberCaroline Shin May 14, 2025 to now9
- Board memberChristopher Hemmeter May 14, 2025 to now8
- Board memberH. Charles Floyd May 14, 2025 to now10
- Board memberRobert Ghoorah May 14, 2025 to now11
- Board memberRoss David Edelman May 14, 2025 to now12
- Board memberWarren B. Riley May 14, 2025 to now13
Timeline
- May 14, 2025New chief executive Christopher Hemmeter becomes CEO8
Filings
50 filings to the SEC since October 2021: 1 annual reports, 5 quarterly reports, 2 major events, 8 insider forms, 11 large holders, 23 other. The latest 20:
- Aug 14, 2026SCHEDULE 13G/A EDGAR
- Aug 13, 202610-Q EDGAR
- May 15, 2026SCHEDULE 13G/A EDGAR
- May 14, 202610-Q EDGAR
- Mar 30, 202610-K EDGAR
- Feb 12, 2026SCHEDULE 13G/A EDGAR
- Feb 6, 2026SCHEDULE 13G EDGAR
- Nov 14, 202510-Q EDGAR
- Nov 14, 2025SCHEDULE 13G/A EDGAR
- Nov 12, 2025SCHEDULE 13G EDGAR
- Aug 14, 2025SCHEDULE 13G EDGAR
- Aug 14, 2025SCHEDULE 13G EDGAR
- Aug 13, 202510-Q EDGAR
- Aug 12, 2025SCHEDULE 13G EDGAR
- Jun 30, 202510-Q EDGAR
- May 30, 2025SCHEDULE 13G EDGAR
- May 23, 20258-K EDGAR
- May 20, 2025SCHEDULE 13G EDGAR
- May 16, 20258-K EDGAR
- May 15, 2025424B4 EDGAR
The 50 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last three years, summarized. The full record is on SEC EDGAR.
Insider trades and holders
Large holders
Investors who own more than 5% must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively. 11 such filings since October 2021, the latest 10:
- Aug 14, 2026SCHEDULE 13G/A
- May 15, 2026SCHEDULE 13G/A
- Feb 12, 2026SCHEDULE 13G/A
- Feb 6, 2026SCHEDULE 13G
- Nov 14, 2025SCHEDULE 13G/A
- Nov 12, 2025SCHEDULE 13G
- Aug 14, 2025SCHEDULE 13G
- Aug 14, 2025SCHEDULE 13G
- Aug 12, 2025SCHEDULE 13G
- May 30, 2025SCHEDULE 13G
From Forms 4 and Schedules 13D and 13G filed with the SEC.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9SEC EDGARCaroline Shin, Board member
- 10SEC EDGARH. Charles Floyd, Board member
- 11SEC EDGARRobert Ghoorah, Board member
- 12SEC EDGARRoss David Edelman, Board member
- 13SEC EDGARWarren B. Riley, Board member